Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.
Wang F, Bank T, Malnassy G, Arteaga M, Shang N, Dalheim A, Ding X, Cotler SJ, Denning MF, Nishimura MI, Breslin P, Qiu W. Wang F, et al. Among authors: malnassy g. Hepatol Commun. 2018 Apr 17;2(6):732-746. doi: 10.1002/hep4.1181. eCollection 2018 Jun. Hepatol Commun. 2018. PMID: 29881824 Free PMC article.
Integrin subunit beta 8 contributes to lenvatinib resistance in HCC.
Hou W, Bridgeman B, Malnassy G, Ding X, Cotler SJ, Dhanarajan A, Qiu W. Hou W, et al. Among authors: malnassy g. Hepatol Commun. 2022 Jul;6(7):1786-1802. doi: 10.1002/hep4.1928. Epub 2022 Mar 3. Hepatol Commun. 2022. PMID: 35238496 Free PMC article.
Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression.
Malnassy G, Keating CR, Gad S, Bridgeman B, Perera A, Hou W, Cotler SJ, Ding X, Choudhry M, Sun Z, Koleske AJ, Qiu W. Malnassy G, et al. Cell Mol Gastroenterol Hepatol. 2023;16(5):685-709. doi: 10.1016/j.jcmgh.2023.07.006. Epub 2023 Jul 15. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37460041 Free PMC article.
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W. Liu H, et al. Among authors: malnassy g. Haematologica. 2012 Apr;97(4):579-85. doi: 10.3324/haematol.2011.050203. Epub 2011 Nov 18. Haematologica. 2012. PMID: 22102709 Free PMC article. Clinical Trial.
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
Odenike O, Halpern A, Godley LA, Madzo J, Karrison T, Green M, Fulton N, Mattison RJ, Yee KW, Bennett M, Koval G, Malnassy G, Larson RA, Ratain MJ, Stock W. Odenike O, et al. Among authors: malnassy g. Invest New Drugs. 2015 Apr;33(2):371-9. doi: 10.1007/s10637-014-0194-2. Epub 2014 Dec 9. Invest New Drugs. 2015. PMID: 25483416 Free PMC article. Clinical Trial.
Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.
Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson RA, Bloomfield CD, Marcucci G, Nakamura Y, Stock W. Alachkar H, et al. Among authors: malnassy g. Pharmacogenomics J. 2017 Jun;17(3):274-279. doi: 10.1038/tpj.2016.7. Epub 2016 Mar 29. Pharmacogenomics J. 2017. PMID: 27019981 Free PMC article. Clinical Trial.
17 results